Top cancer hospitals: objective data, not subjective rankings

Why patient-facing hospital rankings are unreliable. How to evaluate cancer centers using objective signals: NCI designation, CMS star ratings, SEER survival, and volume of care.

“Best cancer hospital” rankings are a staple of patient-facing media, but the most widely circulated lists use opaque methodologies, heavily weight reputation surveys, and rarely correlate with actual outcomes for specific cancers. This page does not rank hospitals. Instead, it explains the objective signals that exist in federal datasets and how to combine them to evaluate a cancer center for your specific situation.

Why reputation-based rankings are weak signals

Popular hospital rankings often weight two factors heavily:

Physician reputation surveys. Surveys ask physicians to name the “best” hospitals in their specialty. This produces results that favor long-established centers regardless of current performance.
Structural measures. Facility size, subspecialist counts, technology availability. These correlate with capability but not necessarily with outcomes for individual patients.

What these rankings typically do not measure well:

Outcomes for your specific cancer type, stage, and biomarker subset
Current performance (rankings lag by years)
Patient experience measures
Value or cost

For cancer specifically, the strongest single signal is subspecialty expertise for your exact cancer. A top-10-ranked hospital may not be the best choice for your rare sarcoma subtype if a lower-ranked center has a dedicated sarcoma program.

Objective signals worth using

NCI designation

The National Cancer Institute designates 72 U.S. cancer centers under a peer-reviewed program. Designation requires demonstrated excellence in laboratory research, clinical research, cancer prevention, control, and population-based research. There are three designation levels:

Comprehensive Cancer Centers (54 centers): the most rigorous designation
Cancer Centers (15 centers): clinical and population research
Basic Laboratory Cancer Centers (3 centers): laboratory research focus

See all NCI-designated cancer centers in the cancer centers directory.

Designation is binary (designated or not), objectively awarded, and reviewed periodically. It is a strong signal of research activity and academic infrastructure. It does not directly measure patient outcomes.

CMS Hospital Compare Overall Rating

CMS publishes an Overall Hospital Star Rating on a 1 to 5 scale based on objective measures:

Mortality
Safety of care
Readmission
Patient experience (HCAHPS survey)
Timely and effective care

This rating covers the whole hospital, not its cancer program specifically, but it reflects the operational quality of the institution treating you. A 5-star general hospital is more likely to also have safe, effective, and responsive cancer care than a 1- or 2-star hospital.

CMS Hospital Compare data is accessible through Medicare.gov Care Compare.

SEER survival outcomes

NCI’s Surveillance, Epidemiology, and End Results (SEER) program publishes cancer-specific five-year relative survival rates. SEER data is aggregated at the regional and national level, not hospital-specific, but provides a reference point for what expected outcomes look like for your cancer type and stage.

Relative survival rates answer the question “what percentage of people with this cancer at this stage are alive five years after diagnosis?” Survival statistics are not prognostic for individual patients, but they contextualize outcomes.

See survival rates by cancer type on the cancer survival rates page.

Volume of care

Research consistently shows that hospitals performing a higher volume of a specific cancer surgery or treatment often have better outcomes for that procedure. This is especially true for complex surgeries (pancreatectomy, esophagectomy, cardiothoracic surgery for lung cancer).

Hospital-specific volume data is harder to find for cancer surgeries specifically. For some procedures, state health department data publishes hospital-level volumes. For others, you may need to ask the hospital directly: “How many [procedure] does your center perform annually?” and “What is your in-hospital mortality rate for this procedure?”

How to combine these signals

For a hospital evaluation with public data:

Start with NCI designation. NCI-designated Comprehensive Cancer Centers have demonstrated research infrastructure and typically the full range of subspecialty expertise. If you have a common cancer and access to one, the designation is a reasonable starting filter.
Check CMS star rating. Prefer 4- or 5-star hospitals. 1- or 2-star overall ratings indicate systemic quality issues worth investigating further.
Ask about volume for your specific procedure. Especially for cancer surgery. Higher-volume centers have better outcomes.
Look for subspecialty expertise in your specific cancer. Many centers have dedicated programs (e.g., Mayo Clinic’s sarcoma program, MD Anderson’s pancreatic cancer program). Subspecialty depth often matters more than overall ranking.
Consider clinical trial availability. Major academic centers offer more trials, which can provide access to newer treatments not available at community hospitals. See how to find a clinical trial.

Combining public data with a second opinion

A second opinion at a major cancer center is the most direct way to calibrate whether your local center is delivering standard-of-care treatment. See how to get a second opinion without a referral. The second-opinion oncologist can also tell you whether specialized centers would offer materially different treatment for your case.

What not to use

Self-reported “best of” lists. Many hospital ranking websites accept payment for inclusion or rely on vote-counting.
Marketing materials. Hospital websites highlight favorable statistics and omit unfavorable ones.
Single patient reviews. Individual patient experiences vary significantly and are not reliable signals of institutional quality.

Find cancer centers

NCI-designated cancer centers directory: all 72 centers with CMS quality data where published
Second opinion programs at top centers: per-cancer and per-hospital second-opinion offerings